• Français
  • Search
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Annual General Meeting
    • CAHR Strategic Plan 2020 – 2025
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Sponsors & Exhibitors
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • CAHR Board Trainee
    • Become a Member
    • CAHR Strategic Plan 2020 – 2025
    • CAHR Annual General Meeting
    • Call for Nominations: CAHR Board of Directors
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media

Oral Abstracts

Click on the Program # to view the abstract.

Click on the Abstract Title to view the presentation on YouTube starting May 1st at 3:30 PM EDT.

Basic Sciences

BS2.01 Characterization of HIV Reservoirs in Multiple Tissues Collected Post-mortem from Two Individuals on Suppressive ART
BS2.02 Pulmonary mucosal double negative T cells as HIV reservoirs during long-term ART
BS2.03 Plasma CXCL13 Correlates with Reservoir Size in Long-term ART-treated People Living With HIV
BS2.05 Hiv-1 Nef Enhances Viral Reactivation from Latency by Stimulating TNF-α Expression
BS3.01 Productively-Infected Cd4 T Cells are Resistant to Non-neutralizing Antibodies
BS3.02 Latency Reversing Agents: impact on Human Macrophages Susceptibility to HIV-1 Infection and Viral Production
BS3.05 Frequencies and Correlates of Endocervical Regulatory T Cells (Treg) Amongst HIV Seronegative Female Sex Workers (FSWs) in Nairobi
BS4.01 Nef Inhibitors as Adjuvants Towards a Cure for HIV/AIDS
BS4.02 Dynamics of regulatory and effector CD8 T-cells in mesenteric lymph nodes and blood during SIV infection of Rhesus Macaques and following early ART initiation
BS4.03 Impact of Early Antiretroviral Therapy on B and CD4 T Cell Dynamics in Lymphoid Tissues of SIV Infected Rhesus Macaques

Clinical Sciences

CS1.01 Neurodevelopmental and Mental Health Co-morbidities in Canadian Children and Adolescents Living with HIV in the EPIC4 cohort
CS1.02 Double Trouble: Increased Risk of Congenital Cytomegalovirus Infection Among HIV-exposed Newborns
CS1.05 Reproductive Toxicity Studies to Evaluate Potential Neural Tube and Other Abnormalities Associated with Dolutegravir Exposure in Pregnancy
CS3.02 Effect of Metformin Treatment on Non-Diabetic HIV-Infected Individuals on ART
CS3.03 Declining Prevalence of Drug Interactions Between Antiretroviral and Other Drugs in Antiretroviral Therapy (ART)-Treated Persons in British Columbia (BC), 2010-2016
CS3.04 Untimed Plasma Efavirenz Levels after Switching from Brand to Generic Formulations
CS3.05 Utility of HIV Drug Resistance Testing in Low Viral Load Samples
CS4.01 Effectiveness of an Intervention to Reengage HIV-Positive Patients Into Care (Lost & Found)
CS4.02 Syndemic Effects of Childhood Adverse Experiences, Depression, and Substance Use on Antiretroviral Non-adherence among Participants of the OHTN Cohort Study

Epidemiology and Public Health Sciences

EPH1.01 Using Administrative Pharmaceutical Prescription Data to Estimate the Number of Persons on HIV Antiretroviral Treatment, Canada, 2014–2018
EPH1.02 A Novel Phylogenetic Approach to Prioritizing HIV-1 Transmission Clusters
EPH1.03 Using Population-level Latent Class Analysis to Classify People Living with HCV in British Columbia (BC) for Targeted Program Planning
EPH1.05 Hepatitis C Virus (HCV) Treatment, Injection Practices, and Access to Harm Reduction among HIV-HCV co-infected People who Inject Drugs in Montréal from 2003-2018
EPH2.02 Depression is associated with bacterial sexually transmitted infections (STIs) among gay, bisexual, and other men who have sex with men (gbMSM)
EPH2.07 Scale-up and Sustainability of Digital Public Health Services for STBBI Testing: an Investigation of Healthcare Service and HIV Policy Context in British Columbia
EPH3.02 Sporadic Clustered Outbreaks of HIV Among MSM Persist in Treatment-as-Prevention Era
EPH3.03 Short-Term Impacts of the Phénix Program: a Promising Community-Based Intervention to Improve gbMSM’s Sexual Health and Wellbeing
EPH4.02 PrEP uptake amongst MSM accessing sexual health services in Ontario and British Columbia – Results of the PrIMP Community Survey
EPH4.05 Uptake of PrEP among Users of Non-occupational PEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montréal (2013 – 2019)

Social Sciences

 

SS1.02 Recent developments in Canada’s approach to HIV criminalization : The role of the Canadian Coalition to Reform HIV Criminalization in fostering change
SS2.01 “People Give and Take a Lot in Order to Participate in Things:”  Making a Case for Non-participation in HIV CBPR and Participatory Programming with Young People
SS3.02 Making “Risk” Visible in Perinatal Care for Mothers Living with HIV in Ontario: An Institutional Ethnography
SS3.06 Social Support and STBBI Transmission Behaviours Among HIV-Negative Gay, Bisexual, and Other Men Who Have Sex with Men (GBM)
SS4.04 Peer Health Advocacy Wellness Network (PHAWN): Commencing a Network of Peers within First Nations Communities in Saskatchewan
SSKP1.02 Barriers to access to antiretroviral treatment and care for people living with HIV with precarious immigration status
SSKP1.03 Celebrate: Love, Laugh & Live Together (Celebrate: 3LT). an Inter-generational Exploration of Grief and Loss Through Story-making
SSKP4.02 How Does HIV Optimism Feature Within the Perspectives and Experiences of Young Sexual and Gender Minority Men? A Discourse Analysis
SSKP4.06 The role of perceived discrimination on suicidal ideation among gay, bisexual and other men who have sex with men in Montreal

Key Populations

KP1.01 Successes and Challenges in Empowerment Strategies amongst Newcomer PHAs: Insights from the Ethno-racial Treatment Support Network Training Evaluation Study
KP2.03 Tracks Survey of people who inject drugs in Canada, Phase 4 2017-2019 – Selected findings among Indigenous participants
KP2.04 Culturally Specific and Gender Based STBBI Interventions Designed by and for Incarcerated Indigenous Women
KP3.01 “I felt safe there”: Implications of an Acute Care Supervised Consumption Service for the Hospital Risk Environment
KP3.02 HIV and HCV Cascade of Care Among People Who Inject Drugs in the SurvUDI Network – 2003 to 2017
KP4.01 Preliminary results of the Dual Daily HIV and Syphilis Pre-Exposure Prophylaxis (DuDHS) Trial.

Virtual Conference

  • Virtual Conference Program
  • Keynote Presentations
  • Special Sessions
  • Oral Abstracts
  • Posters
  • Abstract Book
  • Videos

Our Mission

  • Promote excellence in HIV research
  • Foster collaboration and cooperation among HIV research communities, including basic science, clinical science, epidemiology & public health and social science
  • Promote education and the development of new researchers
  • Provide a unified voice for Canadian HIV researchers and engage diverse stakeholders (community, industry, Government, NGO’s etc.) in ongoing dialogue and knowledge exchange to ensure that HIV research remains responsive to their needs
CAHR 2023 Conference Logo

CAHR 2023
April 27 to 30, 2023

Learn More

Recent News

  • #CAHR2023 - Ancillary Events / #ACRV2023 - Événements connexes myemail.constantcontact.com/CAHR-2023---An…
  • CAHR extends its thanks to all Sponsors of the CAHR 2023 Conference. Learn more on our website, or visit them in the exhibit hall at the conference : cahr-acrv.ca/conference/spo… #CAHR2023 https://t.co/xEI7YTmvUB
  • L'ACRV adresse ses remerciements à tous les commanditaires du congrès ACRV 2023. Vous en saurez plus à leur sujet en consultant notre site Web ou en leur rendant visite à la salle des exposants du congrès : cahr-acrv.ca/fr/congres/spo… qGwC #ACR https://t.co/XIPkTSSQ39
  • For those developing a CAHR 2023 poster or interested in refining your presenting skills, CAHR has an online tutorial that aims to provide you with tips to make your poster one to remember. Click here: rise.articulate.com/share/n61pMfDF… #CAHR2023
  • Cliquez ici : rise.articulate.com/share/wSF8uyi0… #ACRV2023 (2/2)
  • Résultats du concours de bourses de voyage pour professionnels de la santé – 2023
Subscribe to the CAHR Newsletter

About CAHR

With a membership of more than 1,000 researchers and others interested in HIV research, the Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. CAHR is the organizing body for the Annual Canadian Conference on HIV/AIDS Research (CAHR Conference).

CAHR encourages Canadian researchers to be leaders in knowledge translation and to effectively respond both to the Canadian and global HIV/AIDS epidemics. Since its founding in 1991, CAHR has promoted excellence in HIV research, including mentorship and career development of investigators entering the field.

CAHR fosters collaboration and co-operation among HIV research communities, including basic, clinical and social sciences, epidemiology and public health. CAHR also engages people living with HIV/AIDS and AIDS service organizations in ongoing dialogue and information exchange to ensure that HIV/AIDS research remains responsive to the epidemic and its stakeholders.

CAHR is a registered charity.

Links

  • Who We Are
  • Conference
  • Awards
  • Workshops
  • Featured Researchers
  • Student Profiles
  • CAHR News

Contact

For more information or to make a comment, please contact us:

Canadian Association for HIV Research

440 Laurier Avenue West, Suite 200
Ottawa, Ontario K1R 7X6

1-888-374-CAHR (2247)
info@cahr-acrv.ca
  • Media
  • Contact
  • Français